Grand Pharmaceutical Group Ltd
HKEX:512
Wall Street
Price Targets
Price Targets Summary
Grand Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for Grand Pharmaceutical Group Ltd is 7.75 HKD with a low forecast of 7.68 HKD and a high forecast of 7.98 HKD.
Operating Income
Forecast
Operating Income Estimate
Grand Pharmaceutical Group Ltd
For the last 8 years the compound annual growth rate for Grand Pharmaceutical Group Ltd's operating income is 28%. The projected CAGR for the next 2 years is 230%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Grand Pharmaceutical Group Ltd's stock price target?
Price Target
7.75
HKD
According to Wall Street analysts, the average 1-year price target for Grand Pharmaceutical Group Ltd is 7.75 HKD with a low forecast of 7.68 HKD and a high forecast of 7.98 HKD.
What is Grand Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
14%
For the last 8 years the compound annual growth rate for Grand Pharmaceutical Group Ltd's revenue is 16%. The projected CAGR for the next 2 years is 14%.
What is Grand Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
230%
For the last 8 years the compound annual growth rate for Grand Pharmaceutical Group Ltd's operating income is 28%. The projected CAGR for the next 2 years is 230%.
What is Grand Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
23%
For the last 8 years the compound annual growth rate for Grand Pharmaceutical Group Ltd's net income is 34%. The projected CAGR for the next 2 years is 23%.